Multiplex Immunofluorescence News Today

Triple-Negative Breast Cancer (TNBC) is notorious for its poor prognosis and limited treatment options and demands focused investigation and innovative strategies.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Investigators at Johns Hopkins University (JHU) used AstroPath to identify and validate biomarkers for accurate prediction of long-term response to immune...

Applications of Multiplex Immunofluorescence for Immune Biomarkers in Drug Development, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers will discuss the current challenges in drug development and how Invicro, a Konica Minolta Company, applies domain expertise to help pharma sponsors address them. They will highlight the limitations of conventional immunohistochemistry (IHC) methods and discuss how multiplex fluorescent assays can be deployed to detect...